GERD patients self-manage breakthrough symptoms

Language: English

Welcome to EPG Patient Direct

The healthcare portal for patients and the general public in Europe

Conditions and illnesses
Managing your health
Lifestyle advice
Treatment choices

More News Health News

Patients with diabetes experience slowdown of thought processes
Published Monday 05 January 2009
Obese post-menopausal women at greater risk of ovarian cancer
Published Monday 05 January 2009
Study looks at the costs associated with sleep disorders
Published Friday 02 January 2009
Expert advises on a healthy diet for a healthy pocket
Published Wednesday 31 December 2008

Your Vote

Would you expect restaurant food to contain more calories than fast food?

Tools and Links

Find Out More About

This service contains links to third party websites. EPG Patient Direct is not in a position to verify this information and cannot be held responsible for the accuracy of the content contained.

More NewsEPG Patient Direct News

19 May 2008

Almost 40 per cent of gastroesophageal reflux disease (GERD) patients continue to experience symptoms such as acid regurgitation and heartburn, despite daily use of proton pump inhibitors (PPIs), research reveals.

A new survey of 1,064 people conducted by the American Gastroenterological Association (AGA) Institute found that these returning "breakthrough" symptoms result in more than half (56 per cent) of GERD patients turning to over-the-counter remedies.

According to the AGA's findings, over 70 per cent of GERD sufferers use over-the counter medications in addition to prescribed PPIs to manage and control symptoms.

The findings indicated that 65 per cent of GERD sufferers experienced breakthrough at night and 28 per cent report sleep disruption as a result.

Dr John Inadomi, associate professor of medicine at the University of California, San Francisco, commented: "Breakthrough symptoms can be bothersome and frustrating to GERD sufferers, but they aren't talking about it with their physician as often as they should.

"By discussing the frequency, severity and timing of breakthrough symptoms, physicians and patients can determine if changes need to be made to their GERD treatment."

Participants of the study were 40 per cent male, 60 per cent female. All patients had been taking a PPI to control their GERD symptoms for a minimum period of three months.

Click here to visit the Reflux Disease Quick Guide ADNFCR-1528-ID-18599017-ADNFCR

E-mail Bookmark Print

Delicious Reddit Facebook StumbleUpon